沃华医药：2025年前三季度净利润约6399万元

Group 1 - The core viewpoint of the article highlights the financial performance of WoHua Pharmaceutical in Q3 2023, showing significant growth in revenue and net profit [1] - The company's revenue for the first three quarters of 2025 is approximately 625 million yuan, representing a year-on-year increase of 8.31% [1] - The net profit attributable to shareholders of the listed company is about 63.99 million yuan, which is a substantial year-on-year increase of 179.34% [1] - Basic earnings per share are reported at 0.11 yuan, reflecting a year-on-year increase of 175% [1]